In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy.|https://dx.doi.org/10.1128/aac.01222-23
Exposure and resistance to lantibiotics impact microbiota composition and function.|https://dx.doi.org/10.1101/2023.12.30.573728
